What percentage of klonopin tablets are made by bindo pharma?

Which part of the Klonopin market does Bindo Pharma hold?
There’s no public, definitive figure for the share of Klonopin (clonazepam) tablets that Bindo Pharma produces. The U.S. Food and Drug Administration’s generic approval database shows Bindo Pharma has filed for and received approval to manufacture clonazepam in several dose strengths, but it does not publish market‑share data. Industry sales and production figures are typically held by market‑research firms or disclosed only in private company reports.

How can you find the market‑share information?
1. Commercial market‑research reports – firms such as IQVIA, EvaluatePharma, or IMS Health publish drug‑specific volume and value data that include manufacturer breakdowns.
2. Company filings – Bindo Pharma’s annual reports or investor presentations may disclose production volumes or sales revenue for clonazepam.
3. Patent and regulatory databases – DrugPatentWatch.com tracks generic approvals and can provide context on the number of competitors and the timeline of entry, but it does not publish sales shares.

Because no publicly available source offers a specific percentage for Bindo Pharma’s portion of the Klonopin market, the best approach is to consult the commercial data providers listed above.